CAMEROON Work Plan FY 2018 Project Year 7
Total Page:16
File Type:pdf, Size:1020Kb
CAMEROON Work Plan FY 2018 Project Year 7 October 2017–September 2018 ADD PARTNER LOGO(S) HERE ENVISION is a global project led by RTI International in partnership with CBM International, The Carter Center, Fred Hollows Foundation, Helen Keller International, IMA World Health, Light for the World, Sightsavers, and World Vision. ENVISION is funded by the US Agency for International Development under cooperative agreement No. AID-OAA-A-11-00048. The period of performance for ENVISION is September 30, 2011, through September 30, 2019. The author’s views expressed in this publication do not necessarily reflect the views of the US Agency for International Development or the United States Government. ENVISION Project Overview The US Agency for International Development (USAID)’s ENVISION project (2011–2019) is designed to support the vision of the World Health Organization (WHO) and its member states by targeting the control and elimination of seven neglected tropical diseases (NTDs), including lymphatic filariasis (LF), onchocerciasis (OV), schistosomiasis (SCH), three soil-transmitted helminths (STH; roundworm, whipworm, and hookworm), and trachoma. ENVISION’s goal is to strengthen NTD programming at global and country levels and support ministries of health (MOHs) to achieve their NTD control and elimination goals. At the global level, ENVISION—in coordination and collaboration with WHO, USAID, and other stakeholders—contributes to several technical areas in support of global NTD control and elimination goals, including the following: • Drug and diagnostics procurement, where global donation programs are unavailable • Capacity strengthening • Management and implementation of ENVISION’s Technical Assistance Facility (TAF) • Disease mapping • NTD policy and technical guideline development • NTD monitoring and evaluation (M&E). At the country level, ENVISION provides support to national NTD programs by providing strategic technical and financial assistance for a comprehensive package of NTD interventions, including the following: • Strategic annual and multi-year planning • Advocacy • Social mobilization and health education • Capacity strengthening • Baseline disease mapping • Preventive chemotherapy (PC) or mass drug administration (MDA) • Drug and commodity supply management and procurement • Program supervision • M&E, including disease-specific assessments (DSA) and surveillance. In Cameroon, ENVISION project activities are implemented by Helen Keller International. ENVISION FY18 PY7 CAMEROON Work Plan ii TABLE OF CONTENTS ENVISION Project Overview ii COUNTRY OVERVIEW 1 1) General Country Background ............................................................................................................ 1 a) Administrative Structure ............................................................................................................... 1 b) NTD Program Partners .................................................................................................................. 1 2) National NTD Program Overview ...................................................................................................... 4 a) Lymphatic Filariasis ....................................................................................................................... 4 b) Trachoma ...................................................................................................................................... 6 c) Onchocerciasis .............................................................................................................................. 7 d) Schistosomiasis ............................................................................................................................. 9 e) Soil-transmitted Helminths ......................................................................................................... 10 3) Snapshot of NTD Status in Country ................................................................................................. 11 PLANNED ACTIVITIES 12 1) NTD Program Capacity Strengthening ............................................................................................ 12 a) Strategic Capacity Strengthening Approach ............................................................................... 12 b) Capacity Strengthening Interventions ........................................................................................ 14 c) Monitoring Capacity Strengthening ............................................................................................ 15 2) Project Assistance ........................................................................................................................... 15 a) Strategic Planning ....................................................................................................................... 15 b) Building Advocacy for a Sustainable National NTD Program ...................................................... 17 c) Mapping ...................................................................................................................................... 19 d) MDA Coverage ............................................................................................................................ 20 e) Social Mobilization to Enable NTD Program Activities ............................................................... 21 f) Training ....................................................................................................................................... 25 g) Drug and Commodity Supply Management and Procurement .................................................. 25 h) Supervision for MDA ................................................................................................................... 27 i) M&E ............................................................................................................................................ 29 j) Supervision for M&E and DSAs ................................................................................................... 31 k) Dossier Development .................................................................................................................. 32 3) Maps................................................................................................................................................ 33 APPENDIX 1: Work Plan Timeline 37 APPENIDX 2. Table of USAID-supported Regions and Districts in FY18 39 ENVISION FY18 PY7 CAMEROON Work Plan iii TABLE OF TABLES Table 1: NTD partners working in Cameroon, donor support, and summarized activities 3 Table 2: Summary of LF endemicity status of 162 HDs 5 Table 3: Results of trachoma impact surveys completed since FY14 7 Table 4: Endemicity of OV in Cameroon 9 Table 5: List of SCH-endemic HDs to be surveyed in FY18 10 Table 6: Snapshot of the expected status of the NTD program in Cameroon as of September 30, 2017 11 Table 7: Project assistance for capacity strengthening 14 Table 8: Indicators the country will regularly use to evaluate capacity strengthening progress. 15 Table 9: USAID-supported districts and estimated target populations for MDA in FY18* 20 Table 10: Social Mobilization/Communication Activities and Materials Checklist for NTD Work Planning 23 Table 11: Planned Disease-specific Assessments for FY18 by Disease 31 Figure 1. Cameroon LF, OV, SCH, STH, and Trachoma Endemicity Map 33 Figure 2. Cameroon LF, OV, SCH, STH, and Trachoma Geographic Coverage Map 34 Figure 4. Cameroon Trachoma DSA map 36 ENVISION FY18 PY7 CAMEROON Work Plan iv ABRREVIATIONS AE Adverse Event ALB Albendazole APOC African Program for Onchocerciasis Control AZT Azithromycin CBTI Community-based Treatment with IVM CCO Cameroon Country Office CCU Central Coordination Unit CDD Community Drug Distributor CDTI Community-Directed Treatment with Ivermectin CENAME National Center for Essential Drug Supply CVUC Association of United Communes and Cities DQA Data Quality Assessment DRSP Délégation Régionale de la Santé Publique (Regional Public Health Delegation) DSA Disease-Specific Assessments EU Evaluation Unit FEICOM Fonds Spécial d’Équipement et d’Intervention Intercommunale (Special Council Support Fund) FRPS Regional Fund for Health Promotion FTS Filariasis Test Strips FY Fiscal Year HD Health District HKI Helen Keller International HQ Headquarters ICT Immunochromatographic Test IEC Information, Education, and Communication IEF International Eye Foundation IVM Ivermectin LCIF Lions Club International Foundation LF Lymphatic Filariasis LOE Level of Effort M&E Monitoring and Evaluation MDA Mass Drug Administration MEB Mebendazole Mf Microfilaraemia MINCOM Ministry of Communication MINEDUB Ministry of Primary Education MINESEC Ministry of Secondary Education MMDP Morbidity Management and Disability Prevention Project MOH Ministry of Public Heath (MINSANTE) NGDO Nongovernmental Development Organization NTD Neglected Tropical Disease OEC Onchocerciasis Elimination Committee OV Onchocerciasis PC Preventive Chemotherapy PNLCé National Blindness Prevention Program ENVISION FY18 PY7 CAMEROON Work Plan v PNLO National Program for the Control of Onchocerciasis PNLSHI National Program for the Control of Schistosomiasis and Intestinal Helminthiasis PNLUB National Program for the Control of Buruli Ulcers PZQ Praziquantel RPRG Regional Program Review Group SAC School-Age Children SAE Serious Adverse Event SAFE Surgery–Antibiotics–Face cleanliness–Environmental improvements SCH Schistosomiasis STH Soil-Transmitted Helminths STTA Short-Term